APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vendor Neutral Archive (VNA) & PACS

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Vendor Neutral Archive (VNA) & PACS Market Analysis and Forecast 2026-2032

3 May 2026232 pages

Choose your research edition.

Industry ResearchVendor Neutral Archive (VNA) & PACS Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Vendor Neutral Archive (VNA) & PACS Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Vendor Neutral Archive (VNA) & PACS Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vendor Neutral Archive (VNA) & PACS Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Vendor Neutral Archive (VNA) & PACS Market Analysis and Forecast 2026-2032232 pages · $4,950 USD

Market perspective

The global Vendor Neutral Archive (VNA) & PACS market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Vendor Neutral Archive (VNA) & PACS is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Vendor Neutral Archive (VNA) & PACS is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Vendor Neutral Archive (VNA) & PACS is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Vendor Neutral Archive (VNA) & PACS is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Vendor Neutral Archive (VNA) & PACS include GE Healthcare Technologies Inc., Siemens Healthcare Limited, Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Agfa-Gevaert Group, Sectra AB, Hyland Software, Inc., Intelerad Medical Systems Inc and Merative, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Vendor Neutral Archive (VNA) & PACS, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Vendor Neutral Archive (VNA) & PACS, also provides the revenue of main regions and countries. Of the upcoming market potential for Vendor Neutral Archive (VNA) & PACS, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vendor Neutral Archive (VNA) & PACS revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vendor Neutral Archive (VNA) & PACS market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Vendor Neutral Archive (VNA) & PACS revenue, projected growth trends, production technology, application and end-user industry.

Vendor Neutral Archive (VNA) & PACS Segment by Company

GE Healthcare Technologies Inc.

Siemens Healthcare Limited

Canon Medical Systems Corporation

FUJIFILM Holdings Corporation

Agfa-Gevaert Group

Sectra AB

Hyland Software, Inc.

Intelerad Medical Systems Inc

Merative

Novarad Corporation

Esaote SPA

Dedalus s.p.A.

BridgeHead Software Ltd.

PaxeraHealth

Medicasoft

Visus Health IT GmbH

POSTDICOM

Vendor Neutral Archive (VNA) & PACS Segment by Type

CT

MRl

X-rays

Ultrasound

Mammo

PET

Vendor Neutral Archive (VNA) & PACS Segment by Application

Hospital

Surgery Center

Other

Vendor Neutral Archive (VNA) & PACS Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vendor Neutral Archive (VNA) & PACS market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vendor Neutral Archive (VNA) & PACS and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vendor Neutral Archive (VNA) & PACS.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Vendor Neutral Archive (VNA) & PACS in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Vendor Neutral Archive (VNA) & PACS company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vendor Neutral Archive (VNA) & PACS revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CT Major Player Table 3. MRl Major Player Table 4. X-rays Major Player Table 5. Ultrasound Major Player Table 6. Mammo Major Player Table 7. PET Major Player Table 8. Global Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospital Major Player Table 10. Surgery Center Major Player Table 11. Other Major Player Table 12. Vendor Neutral Archive (VNA) & PACS Industry Trends Table 13. Vendor Neutral Archive (VNA) & PACS Industry Drivers Table 14. Vendor Neutral Archive (VNA) & PACS Industry Opportunities and Challenges Table 15. Vendor Neutral Archive (VNA) & PACS Industry Restraints Table 16. Global Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Vendor Neutral Archive (VNA) & PACS Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Vendor Neutral Archive (VNA) & PACS Market Share by Region (2021-2026) Table 19. Global Vendor Neutral Archive (VNA) & PACS Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Vendor Neutral Archive (VNA) & PACS Market Share by Region (2027-2032) Table 21. Global Vendor Neutral Archive (VNA) & PACS Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share by Players (2021-2026) Table 23. Global Vendor Neutral Archive (VNA) & PACS Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Vendor Neutral Archive (VNA) & PACS Key Players Headquarters & Area Served Table 25. Global Vendor Neutral Archive (VNA) & PACS Players, Product Type & Application Table 26. Global Vendor Neutral Archive (VNA) & PACS Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Vendor Neutral Archive (VNA) & PACS by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Vendor Neutral Archive (VNA) & PACS Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Vendor Neutral Archive (VNA) & PACS Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share by Type (2021-2026) Table 33. Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share by Type (2027-2032) Table 34. Global Vendor Neutral Archive (VNA) & PACS Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Vendor Neutral Archive (VNA) & PACS Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share by Application (2021-2026) Table 38. Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share by Application (2027-2032) Table 39. GE Healthcare Technologies Inc. Company Information Table 40. GE Healthcare Technologies Inc. Business Overview Table 41. GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 43. GE Healthcare Technologies Inc. Recent Development Table 44. Siemens Healthcare Limited Company Information Table 45. Siemens Healthcare Limited Business Overview Table 46. Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 48. Siemens Healthcare Limited Recent Development Table 49. Canon Medical Systems Corporation Company Information Table 50. Canon Medical Systems Corporation Business Overview Table 51. Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 53. Canon Medical Systems Corporation Recent Development Table 54. FUJIFILM Holdings Corporation Company Information Table 55. FUJIFILM Holdings Corporation Business Overview Table 56. FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 58. FUJIFILM Holdings Corporation Recent Development Table 59. Agfa-Gevaert Group Company Information Table 60. Agfa-Gevaert Group Business Overview Table 61. Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 63. Agfa-Gevaert Group Recent Development Table 64. Sectra AB Company Information Table 65. Sectra AB Business Overview Table 66. Sectra AB Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Sectra AB Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 68. Sectra AB Recent Development Table 69. Hyland Software, Inc. Company Information Table 70. Hyland Software, Inc. Business Overview Table 71. Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 73. Hyland Software, Inc. Recent Development Table 74. Intelerad Medical Systems Inc Company Information Table 75. Intelerad Medical Systems Inc Business Overview Table 76. Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 78. Intelerad Medical Systems Inc Recent Development Table 79. Merative Company Information Table 80. Merative Business Overview Table 81. Merative Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Merative Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 83. Merative Recent Development Table 84. Novarad Corporation Company Information Table 85. Novarad Corporation Business Overview Table 86. Novarad Corporation Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Novarad Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 88. Novarad Corporation Recent Development Table 89. Esaote SPA Company Information Table 90. Esaote SPA Business Overview Table 91. Esaote SPA Vendor Neutral Archive (VNA) & PACS Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Esaote SPA Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 93. Esaote SPA Recent Development Table 94. Dedalus s.p.A. Company Information Table 95. Dedalus s.p.A. Business Overview Table 96. Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 98. Dedalus s.p.A. Recent Development Table 99. BridgeHead Software Ltd. Company Information Table 100. BridgeHead Software Ltd. Business Overview Table 101. BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 103. BridgeHead Software Ltd. Recent Development Table 104. PaxeraHealth Company Information Table 105. PaxeraHealth Business Overview Table 106. PaxeraHealth Vendor Neutral Archive (VNA) & PACS Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. PaxeraHealth Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 108. PaxeraHealth Recent Development Table 109. Medicasoft Company Information Table 110. Medicasoft Business Overview Table 111. Medicasoft Vendor Neutral Archive (VNA) & PACS Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Medicasoft Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 113. Medicasoft Recent Development Table 114. Visus Health IT GmbH Company Information Table 115. Visus Health IT GmbH Business Overview Table 116. Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 118. Visus Health IT GmbH Recent Development Table 119. POSTDICOM Company Information Table 120. POSTDICOM Business Overview Table 121. POSTDICOM Vendor Neutral Archive (VNA) & PACS Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. POSTDICOM Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 123. POSTDICOM Recent Development Table 124. North America Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Vendor Neutral Archive (VNA) & PACS Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2026) & (US$ Million) Table 127. North America Vendor Neutral Archive (VNA) & PACS Revenue by Application (2027-2032) & (US$ Million) Table 128. North America Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021-2026) & (US$ Million) Table 130. North America Vendor Neutral Archive (VNA) & PACS Revenue by Country (US$ Million) & (2027-2032) Table 131. Europe Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Vendor Neutral Archive (VNA) & PACS Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Vendor Neutral Archive (VNA) & PACS Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021-2026) & (US$ Million) Table 137. Europe Vendor Neutral Archive (VNA) & PACS Revenue by Country (US$ Million) & (2027-2032) Table 138. China Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2026) & (US$ Million) Table 139. China Vendor Neutral Archive (VNA) & PACS Revenue by Type (2027-2032) & (US$ Million) Table 140. China Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2026) & (US$ Million) Table 141. China Vendor Neutral Archive (VNA) & PACS Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Vendor Neutral Archive (VNA) & PACS Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia Vendor Neutral Archive (VNA) & PACS Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Vendor Neutral Archive (VNA) & PACS Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Vendor Neutral Archive (VNA) & PACS Revenue by Region (US$ Million) & (2021-2026) Table 148. Asia Vendor Neutral Archive (VNA) & PACS Revenue by Region (US$ Million) & (2027-2032) Table 149. SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2026) & (US$ Million) Table 150. SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Type (2027-2032) & (US$ Million) Table 151. SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2026) & (US$ Million) Table 152. SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Application (2027-2032) & (US$ Million) Table 153. SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021-2026) & (US$ Million) Table 155. SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Country (US$ Million) & (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Vendor Neutral Archive (VNA) & PACS Image Figure 2. Global Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vendor Neutral Archive (VNA) & PACS Market Size Share 2021 VS 2025 VS 2032 Figure 4. CT Image Figure 5. MRl Image Figure 6. X-rays Image Figure 7. Ultrasound Image Figure 8. Mammo Image Figure 9. PET Image Figure 10. Global Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Vendor Neutral Archive (VNA) & PACS Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospital Image Figure 13. Surgery Center Image Figure 14. Other Image Figure 15. Global Vendor Neutral Archive (VNA) & PACS Market Size (US$ Million) & (2021-2032) Figure 16. Global Vendor Neutral Archive (VNA) & PACS Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Vendor Neutral Archive (VNA) & PACS Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Vendor Neutral Archive (VNA) & PACS Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share by Type (2021-2032) Figure 23. Global Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share by Application (2021-2032) Figure 26. North America Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Vendor Neutral Archive (VNA) & PACS Revenue Share by Type (2021-2032) Figure 28. North America Vendor Neutral Archive (VNA) & PACS Revenue Share by Application (2021-2032) Figure 29. North America Vendor Neutral Archive (VNA) & PACS Revenue Share by Country (2021-2032) Figure 30. United States Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Vendor Neutral Archive (VNA) & PACS Revenue Share by Type (2021-2032) Figure 35. Europe Vendor Neutral Archive (VNA) & PACS Revenue Share by Application (2021-2032) Figure 36. Europe Vendor Neutral Archive (VNA) & PACS Revenue Share by Country (2021-2032) Figure 37. Germany Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Vendor Neutral Archive (VNA) & PACS Revenue Share by Type (2021-2032) Figure 47. China Vendor Neutral Archive (VNA) & PACS Revenue Share by Application (2021-2032) Figure 48. Asia Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Vendor Neutral Archive (VNA) & PACS Revenue Share by Type (2021-2032) Figure 50. Asia Vendor Neutral Archive (VNA) & PACS Revenue Share by Application (2021-2032) Figure 51. Asia Vendor Neutral Archive (VNA) & PACS Revenue Share by Region (2021-2032) Figure 52. Japan Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Vendor Neutral Archive (VNA) & PACS Revenue Share by Type (2021-2032) Figure 60. SAMEA Vendor Neutral Archive (VNA) & PACS Revenue Share by Application (2021-2032) Figure 61. SAMEA Vendor Neutral Archive (VNA) & PACS Revenue Share by Country (2021-2032) Figure 62. Brazil Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Vendor Neutral Archive (VNA) & PACS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • CT
  • MRl
  • X-rays
  • Ultrasound
  • Mammo
  • PET
Applications
  • Hospital
  • Surgery Center
  • Other
Companies covered
  • GE Healthcare Technologies Inc.
  • Siemens Healthcare Limited
  • Canon Medical Systems Corporation
  • FUJIFILM Holdings Corporation
  • Agfa-Gevaert Group
  • Sectra AB
  • Hyland Software, Inc.
  • Intelerad Medical Systems Inc
  • Merative
  • Novarad Corporation
  • Esaote SPA
  • Dedalus s.p.A.
  • BridgeHead Software Ltd.
  • PaxeraHealth
  • Medicasoft
  • Visus Health IT GmbH
  • POSTDICOM

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vendor Neutral Archive (VNA) & PACS Market by Type
  3. 1.2.1 Global Vendor Neutral Archive (VNA) & PACS Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CT
  5. 1.2.3 MRl
  6. 1.2.4 X-rays
  7. 1.2.5 Ultrasound
  8. 1.2.6 Mammo
  9. 1.2.7 PET
  10. 1.3 Vendor Neutral Archive (VNA) & PACS Market by Application
  11. 1.3.1 Global Vendor Neutral Archive (VNA) & PACS Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital
  13. 1.3.3 Surgery Center
  14. 1.3.4 Other
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Vendor Neutral Archive (VNA) & PACS Market Dynamics
  1. 2.1 Vendor Neutral Archive (VNA) & PACS Industry Trends
  2. 2.2 Vendor Neutral Archive (VNA) & PACS Industry Drivers
  3. 2.3 Vendor Neutral Archive (VNA) & PACS Industry Opportunities and Challenges
  4. 2.4 Vendor Neutral Archive (VNA) & PACS Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Vendor Neutral Archive (VNA) & PACS Market Perspective (2021-2032)
  2. 3.2 Global Vendor Neutral Archive (VNA) & PACS Growth Trends by Region
  3. 3.2.1 Global Vendor Neutral Archive (VNA) & PACS Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vendor Neutral Archive (VNA) & PACS Market Size by Region (2021-2026)
  5. 3.2.3 Global Vendor Neutral Archive (VNA) & PACS Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Vendor Neutral Archive (VNA) & PACS Revenue by Players
  2. 4.1.1 Global Vendor Neutral Archive (VNA) & PACS Revenue by Players (2021-2026)
  3. 4.1.2 Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Vendor Neutral Archive (VNA) & PACS Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vendor Neutral Archive (VNA) & PACS Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Vendor Neutral Archive (VNA) & PACS Key Players Headquarters & Area Served
  7. 4.4 Global Vendor Neutral Archive (VNA) & PACS Players, Product Type & Application
  8. 4.5 Global Vendor Neutral Archive (VNA) & PACS Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Vendor Neutral Archive (VNA) & PACS Market CR5 and HHI
  11. 4.6.3 2025 Vendor Neutral Archive (VNA) & PACS Tier 1, Tier 2, and Tier 3
5 Vendor Neutral Archive (VNA) & PACS Market Size by Type
  1. 5.1 Global Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2032)
  3. 5.3 Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share by Type (2021-2032)
6 Vendor Neutral Archive (VNA) & PACS Market Size by Application
  1. 6.1 Global Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2032)
  3. 6.3 Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 GE Healthcare Technologies Inc.
  2. 7.1.1 GE Healthcare Technologies Inc. Company Information
  3. 7.1.2 GE Healthcare Technologies Inc. Business Overview
  4. 7.1.3 GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  5. 7.1.4 GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio
  6. 7.1.5 GE Healthcare Technologies Inc. Recent Developments
  7. 7.2 Siemens Healthcare Limited
  8. 7.2.1 Siemens Healthcare Limited Company Information
  9. 7.2.2 Siemens Healthcare Limited Business Overview
  10. 7.2.3 Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Product Portfolio
  12. 7.2.5 Siemens Healthcare Limited Recent Developments
  13. 7.3 Canon Medical Systems Corporation
  14. 7.3.1 Canon Medical Systems Corporation Company Information
  15. 7.3.2 Canon Medical Systems Corporation Business Overview
  16. 7.3.3 Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
  18. 7.3.5 Canon Medical Systems Corporation Recent Developments
  19. 7.4 FUJIFILM Holdings Corporation
  20. 7.4.1 FUJIFILM Holdings Corporation Company Information
  21. 7.4.2 FUJIFILM Holdings Corporation Business Overview
  22. 7.4.3 FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  23. 7.4.4 FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
  24. 7.4.5 FUJIFILM Holdings Corporation Recent Developments
  25. 7.5 Agfa-Gevaert Group
  26. 7.5.1 Agfa-Gevaert Group Company Information
  27. 7.5.2 Agfa-Gevaert Group Business Overview
  28. 7.5.3 Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Product Portfolio
  30. 7.5.5 Agfa-Gevaert Group Recent Developments
  31. 7.6 Sectra AB
  32. 7.6.1 Sectra AB Company Information
  33. 7.6.2 Sectra AB Business Overview
  34. 7.6.3 Sectra AB Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sectra AB Vendor Neutral Archive (VNA) & PACS Product Portfolio
  36. 7.6.5 Sectra AB Recent Developments
  37. 7.7 Hyland Software, Inc.
  38. 7.7.1 Hyland Software, Inc. Company Information
  39. 7.7.2 Hyland Software, Inc. Business Overview
  40. 7.7.3 Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio
  42. 7.7.5 Hyland Software, Inc. Recent Developments
  43. 7.8 Intelerad Medical Systems Inc
  44. 7.8.1 Intelerad Medical Systems Inc Company Information
  45. 7.8.2 Intelerad Medical Systems Inc Business Overview
  46. 7.8.3 Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Product Portfolio
  48. 7.8.5 Intelerad Medical Systems Inc Recent Developments
  49. 7.9 Merative
  50. 7.9.1 Merative Company Information
  51. 7.9.2 Merative Business Overview
  52. 7.9.3 Merative Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Merative Vendor Neutral Archive (VNA) & PACS Product Portfolio
  54. 7.9.5 Merative Recent Developments
  55. 7.10 Novarad Corporation
  56. 7.10.1 Novarad Corporation Company Information
  57. 7.10.2 Novarad Corporation Business Overview
  58. 7.10.3 Novarad Corporation Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Novarad Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
  60. 7.10.5 Novarad Corporation Recent Developments
  61. 7.11 Esaote SPA
  62. 7.11.1 Esaote SPA Company Information
  63. 7.11.2 Esaote SPA Business Overview
  64. 7.11.3 Esaote SPA Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Esaote SPA Vendor Neutral Archive (VNA) & PACS Product Portfolio
  66. 7.11.5 Esaote SPA Recent Developments
  67. 7.12 Dedalus s.p.A.
  68. 7.12.1 Dedalus s.p.A. Company Information
  69. 7.12.2 Dedalus s.p.A. Business Overview
  70. 7.12.3 Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Product Portfolio
  72. 7.12.5 Dedalus s.p.A. Recent Developments
  73. 7.13 BridgeHead Software Ltd.
  74. 7.13.1 BridgeHead Software Ltd. Company Information
  75. 7.13.2 BridgeHead Software Ltd. Business Overview
  76. 7.13.3 BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  77. 7.13.4 BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Product Portfolio
  78. 7.13.5 BridgeHead Software Ltd. Recent Developments
  79. 7.14 PaxeraHealth
  80. 7.14.1 PaxeraHealth Company Information
  81. 7.14.2 PaxeraHealth Business Overview
  82. 7.14.3 PaxeraHealth Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  83. 7.14.4 PaxeraHealth Vendor Neutral Archive (VNA) & PACS Product Portfolio
  84. 7.14.5 PaxeraHealth Recent Developments
  85. 7.15 Medicasoft
  86. 7.15.1 Medicasoft Company Information
  87. 7.15.2 Medicasoft Business Overview
  88. 7.15.3 Medicasoft Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Medicasoft Vendor Neutral Archive (VNA) & PACS Product Portfolio
  90. 7.15.5 Medicasoft Recent Developments
  91. 7.16 Visus Health IT GmbH
  92. 7.16.1 Visus Health IT GmbH Company Information
  93. 7.16.2 Visus Health IT GmbH Business Overview
  94. 7.16.3 Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Product Portfolio
  96. 7.16.5 Visus Health IT GmbH Recent Developments
  97. 7.17 POSTDICOM
  98. 7.17.1 POSTDICOM Company Information
  99. 7.17.2 POSTDICOM Business Overview
  100. 7.17.3 POSTDICOM Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  101. 7.17.4 POSTDICOM Vendor Neutral Archive (VNA) & PACS Product Portfolio
  102. 7.17.5 POSTDICOM Recent Developments
8 North America
  1. 8.1 North America Vendor Neutral Archive (VNA) & PACS Revenue (2021-2032)
  2. 8.2 North America Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2032)
  3. 8.2.1 North America Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2026)
  4. 8.2.2 North America Vendor Neutral Archive (VNA) & PACS Revenue by Type (2027-2032)
  5. 8.3 North America Vendor Neutral Archive (VNA) & PACS Revenue Share by Type (2021-2032)
  6. 8.4 North America Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2032)
  7. 8.4.1 North America Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2026)
  8. 8.4.2 North America Vendor Neutral Archive (VNA) & PACS Revenue by Application (2027-2032)
  9. 8.5 North America Vendor Neutral Archive (VNA) & PACS Revenue Share by Application (2021-2032)
  10. 8.6 North America Vendor Neutral Archive (VNA) & PACS Revenue by Country
  11. 8.6.1 North America Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021-2026)
  13. 8.6.3 North America Vendor Neutral Archive (VNA) & PACS Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Vendor Neutral Archive (VNA) & PACS Revenue (2021-2032)
  2. 9.2 Europe Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2032)
  3. 9.2.1 Europe Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2026)
  4. 9.2.2 Europe Vendor Neutral Archive (VNA) & PACS Revenue by Type (2027-2032)
  5. 9.3 Europe Vendor Neutral Archive (VNA) & PACS Revenue Share by Type (2021-2032)
  6. 9.4 Europe Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2032)
  7. 9.4.1 Europe Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2026)
  8. 9.4.2 Europe Vendor Neutral Archive (VNA) & PACS Revenue by Application (2027-2032)
  9. 9.5 Europe Vendor Neutral Archive (VNA) & PACS Revenue Share by Application (2021-2032)
  10. 9.6 Europe Vendor Neutral Archive (VNA) & PACS Revenue by Country
  11. 9.6.1 Europe Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021-2026)
  13. 9.6.3 Europe Vendor Neutral Archive (VNA) & PACS Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Vendor Neutral Archive (VNA) & PACS Revenue (2021-2032)
  2. 10.2 China Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2032)
  3. 10.2.1 China Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2026)
  4. 10.2.2 China Vendor Neutral Archive (VNA) & PACS Revenue by Type (2027-2032)
  5. 10.3 China Vendor Neutral Archive (VNA) & PACS Revenue Share by Type (2021-2032)
  6. 10.4 China Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2032)
  7. 10.4.1 China Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2026)
  8. 10.4.2 China Vendor Neutral Archive (VNA) & PACS Revenue by Application (2027-2032)
  9. 10.5 China Vendor Neutral Archive (VNA) & PACS Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vendor Neutral Archive (VNA) & PACS Revenue (2021-2032)
  2. 11.2 Asia Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2032)
  3. 11.2.1 Asia Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2026)
  4. 11.2.2 Asia Vendor Neutral Archive (VNA) & PACS Revenue by Type (2027-2032)
  5. 11.3 Asia Vendor Neutral Archive (VNA) & PACS Revenue Share by Type (2021-2032)
  6. 11.4 Asia Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2032)
  7. 11.4.1 Asia Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2026)
  8. 11.4.2 Asia Vendor Neutral Archive (VNA) & PACS Revenue by Application (2027-2032)
  9. 11.5 Asia Vendor Neutral Archive (VNA) & PACS Revenue Share by Application (2021-2032)
  10. 11.6 Asia Vendor Neutral Archive (VNA) & PACS Revenue by Country
  11. 11.6.1 Asia Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021-2026)
  13. 11.6.3 Asia Vendor Neutral Archive (VNA) & PACS Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue (2021-2032)
  2. 12.2 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Type (2027-2032)
  5. 12.3 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Application (2027-2032)
  9. 12.5 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Country
  11. 12.6.1 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Vendor Neutral Archive (VNA) & PACS Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst